Table 2 Characteristics of treatment and response by histology
MCBn(%) | TN-ILCn(%) | HG-IDCn(%) | TN-IDCn(%) | pvalue | ||
|---|---|---|---|---|---|---|
Amount received | 24 | 37 | 48 | 48 | ||
Ind CT | 12 (50) | 20 (54.1) | 38 (79.2) | 39 (81.3) | <0.003 | |
Response | pPR | 2 (16.7) | 15 (75) | 26 (65) | 24 (61.5) | <0.001 |
pCR | 3 (25.0) | 2 (10.0) | 12 (30) | 11 (28.2) | ||
Stable | 1 (8.3) | 1 (5) | 0 | 2 (5.1) | ||
Progression | 6 (50) | 2 (10) | 2 (5) | 2 (5.1) | ||
Surgery | BCS | 0 | 0 | 3 (6.3) | 7 (14.6) | 0.011 |
MRM | 22 (91.7) | 24 (64.9) | 38 (79.2) | 37 (77.1) | ||
No | 2 (8.3) | 13 (35.1) | 7 (14.6) | 4 (8.3) | ||
Adjuvancy | Received | 14 (58.3) | 26 (70.3) | 37 (77.1) | 29 (60.4) | 0.245 |
CT | 11 (45.8) | 22 (59.5) | 19 (39.6) | 36 (75.0) | 0.009 | |
RT | 14 (58.3) | 22 (59.5) | 23 (47.9) | 27 (56.3) | 0.705 | |
Recurrence | No | 15 (62.5) | 13 (35.1) | 28 (58.3) | 29 (60.4) | 0.094 |
Recurrence | 3 (12.5) | 12 (32.4) | 18 (37.5) | 16 (33.3) | ||
Progression | 6 (25) | 12 (32.4) | 2 (4.2) | 3 (6.3) |